Keloids - Pipeline Review, H2 2016 - Key Players are FirstString Research, RXi Pharmaceuticals Corp, Topadur Pharma AG, Tumorend LLC, viDA Therapeutics & Yuhan Corp - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Keloids - Pipeline Review, H2 2016" report to their offering.

Keloids are a growth of extra scar tissue where the skin has healed after an injury. Symptoms include flesh-colored, red, or pink, lumpy (nodular) or ridged, irritated from friction such as rubbing on clothing and tender and itchy. Risk factors include age and family history. Treatment includes corticosteroid, radiation, surgical removal and silicone gel or patches.

This report provides comprehensive information on the therapeutic development for Keloids, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Keloids and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Mentioned

  • FirstString Research Inc
  • RXi Pharmaceuticals Corp
  • Topadur Pharma AG
  • Tumorend LLC
  • viDA Therapeutics Inc
  • Yuhan Corp

Key Topics Covered:

  1. Introduction
  2. Keloids Overview
  3. Therapeutics Development
  4. Pipeline Products for Keloids - Overview
  5. Pipeline Products for Keloids - Comparative Analysis
  6. Keloids - Therapeutics under Development by Companies
  7. Keloids - Therapeutics under Investigation by Universities/Institutes
  8. Keloids - Pipeline Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Keloids - Products under Development by Companies
  13. Keloids - Products under Investigation by Universities/Institutes
  14. Keloids - Companies Involved in Therapeutics Development

For more information about this report visit http://www.researchandmarkets.com/research/cmmrxf/keloids

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Dermatological Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Dermatological Drugs